How the shakeup at OpenAI underscores the need for AI standards in health care
The leadership turmoil within OpenAI, the maker of ChatGPT, is triggering calls for stepped-up efforts to establish standards for how generative AI is used across the health care industry, where experts worry that one or two companies could end up with too much control.
Microsoft was already a driving force behind efforts to deploy generative AI in health care. But its hiring of Sam Altman and Greg Brockman, formerly top executives at OpenAI, gives the company even more power over the technology’s development, testing, and use in the care of patients.
